Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Mysore S. Anil Kumar"'
Autor:
Gregory Malat, Rahul M. Jindal, Suzanne M. Boyle, Meera N. Harhay, Gary Xiao, Mysore S. Anil Kumar, Dong Heun Lee, Alden Doyle, Stephen Guy, Karthik Ranganna
Publikováno v:
American Journal of Kidney Diseases. 73:112-118
Hahnemann University Hospital has performed 120 kidney transplantations in human immunodeficiency virus (HIV)-positive individuals during the last 16 years. Our patient population represents ∼10% of the entire US population of HIV-positive kidney r
Autor:
Xuegong Wang, Kim Papp, Udaya Valluri, Ryo Tainaka, Christian Schwabe, Mysore S. Anil Kumar, Tong Zhu
Publikováno v:
Biopharmaceutics & Drug Disposition. 39:245-255
This study evaluated the pharmacokinetics (PK), efficacy, safety, and tolerability of bleselumab - a fully-human anti-CD40 monoclonal recombinant IgG4. Patients with moderate-to-severe psoriasis were randomized on day 1 to receive bleselumab or place
Publikováno v:
Advances in Therapy
Introduction We qualitatively examined the symptoms and impact of recurrent primary focal segmental glomerulosclerosis (rpFSGS) in kidney transplant recipients, compared with two related FSGS populations, to characterize the experience of patients wi
Autor:
Tami Jo Larson, Jonathan S. Bromberg, Stephen Jensik, Goran B. Klintmalm, Vicki Santos, Xuegong Wang, Robert C. Harland, Mysore S Anil Kumar, Harold Yang, John Holman
Publikováno v:
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant SurgeonsREFERENCES. 20(1)
This study assessed the efficacy and safety of the anti-CD40 monoclonal antibody bleselumab (ASKP1240) in de novo kidney transplant recipients over 36 months posttransplant. Transplant recipients were randomized (1:1:1) to standard of care (SoC: 0.1
Autor:
Mysore S, Anil Kumar, Kim, Papp, Ryo, Tainaka, Udaya, Valluri, Xuegong, Wang, Tong, Zhu, Christian, Schwabe
Publikováno v:
Biopharmaceutics & Drug Disposition
This study evaluated the pharmacokinetics (PK), efficacy, safety, and tolerability of bleselumab – a fully‐human anti‐CD40 monoclonal recombinant IgG4. Patients with moderate‐to‐severe psoriasis were randomized on day 1 to receive bleseluma
Publikováno v:
Drugs. 69:2045-2062
Among organ transplant recipients, the African American population historically has received special attention. This is because secondary to their disposition to certain disease states, for example hypertension, an African American patient has a prop
Autor:
Terry Boodhoo, Renee Greco, Mysore S. Anil Kumar, Vijay Yeldandi, Rocco C. Venuto, Talat Ashraf, Steven M. Steinberg, Chakko K. Kuruvila, David O. Taylor, Jessie R. Groothuis, Joan Ryan
Publikováno v:
Clinical Therapeutics. 25:2037-2052
Prior research has indicated patient dissatisfaction with the odor, size, and taste of cyclosporine capsules, as well as the halitosis and body odor the capsules can cause.The purposes of this investigation were to (1) compare the overall cyclosporin
Autor:
Joseph Brezin, Christopher M. Dezii, Mary McSorley, George M. Abouna, D A Laskow, D Panigrahi, Robert Chvala, Shiela M. Katz, A.M.S Kumar, Mysore S. Anil Kumar
Publikováno v:
Transplantation. :282-285
Background. Traditionally, elderly donor kidneys have not been widely accepted for transplantation on the assumption of inferior performance. However, the United Network for Organ Sharing reports an increase in the number of elderly donors from less
Autor:
Flavio Vincenti, Amado Andrés, Norio Yoshimura, José Manuel González-Posada, Gabriel Choukroun, Edward H. Cole, Lionel Rostaing, Mysore S. Anil Kumar, Kazuhide Saito, Björn Nashan, Silvio Nadalin, Richard Moore, Thomas Becker
Publikováno v:
Transplant international : official journal of the European Society for Organ Transplantation. 19(6)
Summary Addition of interleukin-2 receptor antagonist (IL-2RA) induction to calcineurin inhibitor (CNI)-based regimens reduces biopsy-proven acute rejection by 30–40%. IL-2RA induction facilitates early withdrawal of steroids, and supports the safe
Autor:
Daniel E. Dunn, Shoichi Nagakura, Spencer W. Green, Martha Kirby, Neal S. Young, Mysore S. Anil Kumar, Stephen J. Rosenfeld, Patcharin Tanawattanacharoen, Piernicola Boccuni
Publikováno v:
Annals of internal medicine. 131(6)
Paroxysmal nocturnal hemoglobinuria (PNH) is an acquired hematopoietic stem-cell disorder in which the affected cells are deficient in glycosylphosphatidylinositol (GPI)-anchored proteins. Paroxysmal nocturnal hemoglobinuria is frequently associated